DANA JENNINGS: Open Payments
NPI 1316049455 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 28 payments from 13 companies in 2025. Trend: 2023 $565 · 2024 $733 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $195 |
| Galderma Laboratories, L.P. | 1 | $150 |
| Amgen Inc. | 2 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| GENZYME CORPORATION | 2 | $29 |
| ABBVIE INC. | 2 | $28 |
| Almirall LLC | 1 | $26 |
| Incyte Corporation | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Bimzelx, NEMLUVIO, DUPIXENT, OTEZLA, ILUMYA, SKYRIZI, Seysara, OPZELURA.
Industry payments across KY — which companies pay providers there.
